July 2021
Insist! on Better Care
Biomarker testing in Chronic Lymphocytic Leukemia (CLL) is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! CLL is to educate and empower patients and care partners to speak up and insist on better care.
Understanding Testing in CLL
CLL Treatment Decisions
Related Resources: Your CLL Navigator
This program is supported by AbbVie, Janssen, and Pharmacyclics, and through generous donations from people like you.